MedPath

Tetrabenazine

These highlights do not include all the information needed to use TETRABENAZINE TABLETS safely and effectively. See full prescribing information for TETRABENAZINE TABLETS. TETRABENAZINE tablets, for oral useInitial U.S. Approval: 2008

Approved
Approval ID

aca55884-1eb4-4a76-8c7f-96c782849337

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 31, 2023

Manufacturers
FDA

Precision Dose Inc.

DUNS: 035886746

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TETRABENAZINE

PRODUCT DETAILS

NDC Product Code68094-805
Application NumberANDA207682
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 31, 2023
Generic NameTETRABENAZINE

INGREDIENTS (6)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TETRABENAZINEActive
Quantity: 25 mg in 1 1
Code: Z9O08YRN8O
Classification: ACTIB
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

TETRABENAZINE

PRODUCT DETAILS

NDC Product Code68094-905
Application NumberANDA207682
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 31, 2023
Generic NameTETRABENAZINE

INGREDIENTS (5)

LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
TETRABENAZINEActive
Quantity: 12.5 mg in 1 1
Code: Z9O08YRN8O
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tetrabenazine - FDA Drug Approval Details